From RxTi's Webinar Series: Good Business Practices (GBP)

Few sites enjoy the feasibility process; but then again few sites provide reliable estimates of how many subjects they will enroll. Sponsors and CROs are paying more attention to how sites perform vs. targets, so it will become increasingly important for sites to accurately state what they can do, and then deliver on that. Proper feasibility – including basic recruitment planning - is labor-intense and time-sensitive, but getting it right is critical to a site’s profitability and reputation.

What you'll learn:

• What sites must do to conduct thorough feasibility beyond what’s on the questionnaire
• How sponsors and CROs evaluate your responses (including when you decline a study)
• Poor feasibility’s effect on your bottom line
   

About the presenter:

Adam Chasse, Vice President of Corporate Development of RxTrials, has conducted training workshops throughout the world in general management, strategy development, and operations. He has presented at numerous pharmaceutical research conferences on topics such as strategic alliances, human resource management, operational processes, contracting, budgeting/forecasting, and the state of the clinical research industry.